首页> 外文OA文献 >A Recombinant Sendai Virus Is Controlled by CD4+ Effector T Cells Responding to a Secreted Human Immunodeficiency Virus Type 1 Envelope Glycoprotein▿
【2h】

A Recombinant Sendai Virus Is Controlled by CD4+ Effector T Cells Responding to a Secreted Human Immunodeficiency Virus Type 1 Envelope Glycoprotein▿

机译:重组仙台病毒由对分泌型人类免疫缺陷病毒1型包膜糖蛋白应答的CD4 +效应T细胞控制。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The importance of antigen-specific CD4+ helper T cells in virus infections is well recognized, but their possible role as direct mediators of virus clearance is less well characterized. Here we describe a recombinant Sendai virus strategy for probing the effector role(s) of CD4+ T cells. Mice were vaccinated with DNA and vaccinia virus recombinant vectors encoding a secreted human immunodeficiency virus type 1 (HIV-1) envelope protein and then challenged with a Sendai virus carrying a homologous HIV-1 envelope gene. The primed mice showed (i) prompt homing of numerous envelope-primed CD4+ T cell populations to the virus-infected lung, (ii) substantial production of gamma interferon, and interleukin-2 (IL-2), IL-4, and IL-5 in that site, and (iii) significantly reduced pulmonary viral load. The challenge experiments were repeated with immunoglobulin−/− μMT mice in the presence or absence of CD8+ and/or CD4+ T cells. These selectively immunodeficient mice were protected by primed CD4+ T cells in the absence of antibody or CD8+ T cells. Together, these results highlight the role of CD4+ T cells as direct effectors in vivo and, because this protocol gives such a potent response, identify an outstanding experimental model for further dissecting CD4+ T-cell-mediated immunity in the lung.
机译:抗原特异性CD4 +辅助性T细胞在病毒感染中的重要性已广为人知,但它们作为病毒清除的直接介体的可能作用尚不十分清楚。在这里,我们描述了一种重组仙台病毒策略,用于探测CD4 + T细胞的效应子作用。用编码已分泌的人类免疫缺陷病毒1型(HIV-1)包膜蛋白的DNA和牛痘病毒重组载体对小鼠进行疫苗接种,然后用携带同源HIV-1包膜基因的仙台病毒进行攻击。致敏的小鼠显示(i)迅速将大量包膜致敏的CD4 + T细胞群体归巢到病毒感染的肺中;(ii)大量产生γ干扰素和白介素2(IL-2),IL-4和IL -5在该部位,并且(iii)大大降低了肺病毒载量。在存在或不存在CD8 +和/或CD4 + T细胞的情况下,用免疫球蛋白-/-μMT小鼠重复进行攻击实验。这些选择性免疫缺陷的小鼠在没有抗体或CD8 + T细胞的情况下受到引发的CD4 + T细胞的保护。总之,这些结果突出了CD4 + T细胞作为体内直接效应器的作用,并且由于该方案可产生如此有效的应答,因此鉴定出了杰出的实验模型,可进一步解剖肺中CD4 + T细胞介导的免疫力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号